Asceneuron discovers and develops groundbreaking therapeutics for neurodegenerative disorders with high unmet medical needs: orphan tauopathies, Alzheimer’s and Parkinson’s diseases. A subsidiary of Merck KGaA.

Location

EPFL Innovation Park, 1015 Lausanne, Switzerland

Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    2012
  • Number of employees in Switzerland
    1-9
Key business